Hypothesis: Immunotherapy by Selective Convalescent Blood Engineering to Stifle Diseases like COVID-19

This report incorporates all these aspects by suggesting a novel treatment therapy called selective convalescent leukapheresis and transfusion (SCLT) and also highlights its potential in vaccination. The anticipated advantages of the proposed technique outweigh the cost, time, and efficiency of other available transfusion and vaccination processes. It is envisioned that in the future this new approach could serve as a rapid emergency response to subdue a pathogen outbreak and to stop it from becoming an epidemic, or pandemic.PMID:34522165 | PMC:PMC8436102 | DOI:10.7150/ijms.46363
Source: International Journal of Medical Sciences - Category: Biomedical Science Authors: Source Type: research

Related Links:

This report incorporates all these aspects by suggesting a novel treatment therapy called selective convalescent leukapheresis and transfusion (SCLT) and also highlights its potential in vaccination. The anticipated advantages of the proposed technique outweigh the cost, time, and efficiency of other available transfusion and vaccination processes. It is envisioned that in the future this new approach could serve as a rapid emergency response to subdue a pathogen outbreak and to stop it from becoming an epidemic, or pandemic.PMID:34522165 | PMC:PMC8436102 | DOI:10.7150/ijms.46363
Source: International Journal of Medical Sciences - Category: Biomedical Science Authors: Source Type: research
More News: Biomedical Science | COVID-19 | Emergency Medicine | Epidemics | Epidemiology | Immunotherapy | Outbreaks | Pandemics | Vaccines